Periodic limb movements (PLMs) during sleep are associated with white matter hyperintensities (WMHs) among patients with incident minor stroke and transient ischemic attack (TIA), according to study results published in Sleep.

Previous studies have reported that PLMs during sleep are associated with nocturnal fluctuations in heart rate and blood pressure and vascular events. As such, some researchers posit that PLMs may contribute to cerebrovascular and cardiovascular disease – although this relationship remains debated.

To evaluate the relationship between PLMs and cerebral small vessel disease, investigators conducted a study using data from the Sleep Disorders Managed and Assessed Rapidly in TIA and In Early Stroke (SMARTIES; NCT01528462) and SLEep APnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke (SLEAP SMART; NCT02454023) studies. The investigators assessed periodic limb movement index (PLMI), PLM arousal index (PLMAI), and signs of cerebral small vessel disease (CSVD) among patients (N=86) with recent, first-ever stroke or TIA. Limb movement outcomes were measured using polysomnography and CSVD outcomes were measured using magnetic resonance imaging.

Of the 86 patients included in the study, 66.3% were male, 52.3% had hypertension, 10.5% had diabetes mellitus, 29.1% smoked, 29.1% had microbleeds, and 24.4% had lacunar infarcts. The patients had a mean age of 62.2 (SD=14.3) years and a body mass index (BMI) of 28.1 (SD=5.7) kg/m2.

In conclusion, this study adds to the literature examining the relationship between PLMs and CSVD in patients with cerebrovascular disease,

The patients had a median Fazekas total score of 2 (IQR, 1-3) and an age-related white matter changes (ARWMC) total score of 5 (IQR, 2-10). The subset of patients with a PLMI of 5 or greater (n=36) had significantly higher Fazekas (P =.003) and ARWMC (P =.007) total scores than those with lower PLMI.

In the adjusted models, Fazekas total score was significantly associated with a PLMAI of 5 or greater (adjusted odds ratio [aOR], 5.9; 95% CI, 1.5-23.8; P =.01), PLMI of 5 or greater (aOR, 2.8; 95% CI, 1.2-6.8; P =.02), and a PLMI of the upper limit of normal or higher (aOR, 2.6; 95% CI, 1.0-6.5; P =.04). Additionally, ARWMC total scores were associated with a PLMAI of 5 or greater (adjusted b [ab], 3.8; 95% CI, 0.5-7.1; P =.027) and a PLMI of 5 or greater (ab, 2.3; 95% CI, 0.07-4.4; P =.043).

In a subgroup analysis among only patients with an elevated PLMI, no significant trends in CSVD outcomes were observed on the basis of obstructive sleep apnea status.

“In conclusion, this study adds to the literature examining the relationship between PLMs and CSVD in patients with cerebrovascular disease,” the study authors noted. “These findings suggested that an elevated PLM index was independently associated with WMHs; further work is needed to determine the directionality of this association.”

Study limitations include potential unaccounted confounding and the inability to determine the directionality of the findings.

This article originally appeared on Sleep Wake Advisor